Skip to product information
1 of 1

Mouse Anti-Human/Mouse T-Bet Antibody (S-4477)

Mouse Anti-Human/Mouse T-Bet Antibody (S-4477)

Catalog Number: S0B80028 Application: ICFCM Reactivity: Human,Mouse Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen T-Bet
Synonyms T-box transcription factor TBX21; T-cell-specific T-box transcription factor T-bet; Transcription factor TBLYM; TBET; TBLYM; TBX21
Location Nucleus
Accession Q9UL17、Q9JKD8
Clone Number S-4477
Antibody Type Mouse mAb
Isotype IgG1,k
Application ICFCM
Reactivity Hu, Ms
Purification Protein G
Concentration 2 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS pH7.4

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
ICFCM 1:200 Hu, Ms

Background

T-bet (T-box transcription factor TBX21) is a master regulator protein essential for the differentiation and function of T helper 1 (Th1) cells, playing a pivotal role in the adaptive immune response against intracellular pathogens such as viruses and bacteria. Encoded by the TBX21 gene, this nuclear transcription factor binds to specific DNA sequences to activate the expression of hallmark Th1 cytokines, most notably interferon-gamma (IFN-γ), while simultaneously repressing the development of alternative T cell lineages like Th2 and Th17 by inhibiting their respective lineage-defining transcription factors (GATA3 and RORγt). Beyond its critical function in CD4+ T cells, T-bet also governs the maturation and cytotoxic potential of CD8+ T cells and natural killer (NK) cells, thereby orchestrating a robust cell-mediated immunity; however, its dysregulation or overexpression is implicated in various autoimmune disorders and chronic inflammatory conditions, making it a significant target for immunotherapeutic interventions aimed at modulating immune balance.